An expert workgroup has developed the first appropriate use recommendations (AURs) for real-world use of the antiamyloid donanemab (Kisunla). “The role of appropriate use recommendations are to bridge ...
In 1989, the Institute of Medicine (IOM) convened a committee on utilization management (UM) to examine the growing role of UM in the US health care system and assess its potential effects on patient ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback